EP2596131A4 - Profilage d'expression génique pour l'identification du cancer du poumon - Google Patents

Profilage d'expression génique pour l'identification du cancer du poumon

Info

Publication number: EP2596131A4
Authority: EP; European Patent Office
Prior art keywords: identification; gene expression; lung cancer; expression profiling; copd
Prior art date: 2010-07-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP11810327.4A

Other languages

German (de)

English (en)

Other versions

EP2596131A2 (fr

Inventor

Karl Wassmann

Danute M Bankaitis-Davis

Kathleen Storm

Lisa Siconolfi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

DxTerity Diagnostics

Original Assignee

DxTerity Diagnostics

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-07-21

Filing date

2011-07-20

Publication date

2013-12-18

2011-07-20 Application filed by DxTerity Diagnostics filed Critical DxTerity Diagnostics

2013-05-29 Publication of EP2596131A2 publication Critical patent/EP2596131A2/fr

2013-12-18 Publication of EP2596131A4 publication Critical patent/EP2596131A4/fr

Status Withdrawn legal-status Critical Current

Links

208000020816 lung neoplasm Diseases 0.000 title abstract 2
206010058467 Lung neoplasm malignant Diseases 0.000 title 1
238000011223 gene expression profiling Methods 0.000 title 1
201000005202 lung cancer Diseases 0.000 title 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Physics & Mathematics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Spectroscopy & Molecular Physics (AREA)
Theoretical Computer Science (AREA)
Zoology (AREA)
Immunology (AREA)
Medical Informatics (AREA)
Pathology (AREA)
Evolutionary Biology (AREA)
Analytical Chemistry (AREA)
Bioinformatics & Computational Biology (AREA)
Wood Science & Technology (AREA)
Oncology (AREA)
Microbiology (AREA)
Hospice & Palliative Care (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

EP11810327.4A 2010-07-21 2011-07-20 Profilage d'expression génique pour l'identification du cancer du poumon Withdrawn EP2596131A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US36633110P	2010-07-21	2010-07-21
PCT/US2011/044648 WO2012012510A2 (fr)	2010-07-21	2011-07-20	Profilage d'expression génique pour l'identification du cancer du poumon

Publications (2)

Publication Number	Publication Date
EP2596131A2 EP2596131A2 (fr)	2013-05-29
EP2596131A4 true EP2596131A4 (fr)	2013-12-18

Family

ID=45497433

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP11810327.4A Withdrawn EP2596131A4 (fr)	2010-07-21	2011-07-20	Profilage d'expression génique pour l'identification du cancer du poumon

Country Status (2)

Country	Link
EP (1)	EP2596131A4 (fr)
WO (1)	WO2012012510A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6240804B1 (ja) *	2017-04-13	2017-11-29	大▲連▼大学	改良した情報測定とｇａに基づくフィルター式特徴選択アルゴリズム
CN110699457B (zh) *	2019-10-30	2022-11-25	深圳瑞科生物科技有限公司	检测肺癌的引物组和试剂盒

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006080597A1 (fr) *	2005-01-31	2006-08-03	Digital Genomics Inc.	Marqueurs destines au diagnostic de cancer du poumon
WO2008063413A2 (fr) *	2006-11-13	2008-05-29	Source Precision Medicine, Inc.	Détermination du profil de l'expression génique dans l'identification, la surveillance et le traitement du cancer du poumon

2011
- 2011-07-20 EP EP11810327.4A patent/EP2596131A4/fr not_active Withdrawn
- 2011-07-20 WO PCT/US2011/044648 patent/WO2012012510A2/fr not_active Ceased

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006080597A1 (fr) *	2005-01-31	2006-08-03	Digital Genomics Inc.	Marqueurs destines au diagnostic de cancer du poumon
WO2008063413A2 (fr) *	2006-11-13	2008-05-29	Source Precision Medicine, Inc.	Détermination du profil de l'expression génique dans l'identification, la surveillance et le traitement du cancer du poumon

Also Published As

Publication number	Publication date
WO2012012510A2 (fr)	2012-01-26
EP2596131A2 (fr)	2013-05-29
WO2012012510A3 (fr)	2012-05-24

Similar Documents

Publication	Publication Date	Title
EP2591357A4 (fr)	2014-01-01	Biomarqueurs du cancer du poumon et leurs utilisations
CY1122247T1 (el)	2020-07-31	Αγωγη καρκινων με τη χρηση τροποποιητων ισομορφης κινασης ρι3
SG10202001482YA (en)	2020-04-29	Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers
IL252163A0 (en)	2017-07-31	Lung cancer biomarkers and uses thereof
IL257330B (en)	2020-11-30	Compositions, methods and kits for diagnosis of lung cancer
EP3607089A4 (fr)	2020-12-30	Profilage de protéine à base de plasma pour le pronostic précoce du cancer du poumon
EP2411003A4 (fr)	2012-10-17	Utilisation de dérivés de l'artémisinine dans le traitement de l'asthme et de la broncho-pneumopathie obstructive chronique (bpco)
IL225262A0 (en)	2013-06-27	Methods and compositions for treating lung cancer
MX366130B (es)	2019-06-28	Inhibidores bivalentes de las proteinas iap y métodos terapéuticos que usan los mismos.
EP2340506A4 (fr)	2012-02-15	Biomarqueurs de cancer du poumon et utilisations associées
NZ731797A (en)	2018-08-31	Dna-pk inhibitors
EP2401406A4 (fr)	2012-09-19	Procédés de détection du cancer du poumon
MX2011008799A (es)	2011-09-27	Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados.
WO2012125712A3 (fr)	2012-12-27	Système de classification des tumeurs du poumon pour fumeurs et anciens fumeurs.
PL3329281T3 (pl)	2020-06-01	Nieinwazyjne wykrywanie nowotworu pochodzącego z tkanki poza płucem przy użyciu wydychanego powietrza
MX2019000091A (es)	2023-04-27	Metodo para el pronostico y tratamiento de cancer metastasico de los huesos originado de cancer de mama.
HUE045731T2 (hu)	2020-01-28	Mikro-RNS biomarkerek tüdõtumor diagnosztizálásához és/vagy kockázatának azonosításához
EP2694972B8 (fr)	2017-08-16	Procédés pour prédire et améliorer la survie de patients atteints de cancer gastrique
GB201608839D0 (en)	2016-07-06	Biomarkers useful for detectionof types, grades and stages of human breast cancer
EP3152560A4 (fr)	2018-01-10	Détection de mutation génique non-effractive chez des patients atteints du cancer du poumon
MX2019013468A (es)	2020-02-12	Metodos para tratar la enfermedad pulmonar obstructiva cronica usando benralizumab.
HUE054864T2 (hu)	2021-10-28	In vitro módszer tüdõrák diagnosztizálására
EP2921858A4 (fr)	2016-09-21	Procédé d'obtention de données utiles pour le diagnostic, le pronostic et le classement des patients souffrant d'une broncho-pneumopathie chronique obstructive (bcpo) et/ou d'un cancer du poumon
PH12015500388A1 (en)	2015-04-27	Cancer diagnostic and therapeutic method targeting molecules expressed in cancer stem cells
MX2015017120A (es)	2016-10-05	Combinaciones para el tratamiento de cancer que comprende un inhibidor de la quinasa mps-1 y un inhibidor de la mitosis.

Legal Events

Date	Code	Title	Description
2013-04-26	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2013-05-29	17P	Request for examination filed	Effective date: 20130204
2013-05-29	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2013-10-30	DAX	Request for extension of the european patent (deleted)
2013-12-18	A4	Supplementary search report drawn up and despatched	Effective date: 20131118
2013-12-18	RIC1	Information provided on ipc code assigned before grant	Ipc: C12Q 1/68 20060101AFI20131112BHEP Ipc: G06F 19/20 20110101ALI20131112BHEP
2014-06-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2014-07-09	18D	Application deemed to be withdrawn	Effective date: 20140201